Gareeva, A.E.,
Sharafiev, R.R.,
Akhmetova, E.A.,
Nasibullin, T.R.,
Fakhurtdinova, Z.R.,
Yuldashev, V.L.,
Asadullin, A.R. (2020) cannabinoids taking account of the combined influences of genetic predisposition and
attention deficit hypera-ctivityНЕВРОЛОГИЧЕСКИЕ И ПСИХИЧЕСКИЕ РАССТРОЙСТВА, АССОЦИИРОВАННЫЕ С COVID-19НОВИКОВА, Л.Б.,
АКОПЯН, А.П.,
ШАРАПОВА, К.М.,
ЛАТЫПОВА, Р.Ф.,
NOVIKOVA L.B.,
AKOPIAN A.P.,
SHARAPOVA K.M.,
LATYPOVA R.F. (2020) The article presents a narrative review, clinical observations. Special
attention is given
MEAD, G.E.,
LEGG, L.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.,
DENNIS, M.S.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J. (2020) to patients who did not have to have mood
disorders at randomization reduced disability, dependency
URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) activated TEG, in vitro hemostatic system
hyperactivity modeling was carried out with the blood of healthy